GraniteShares Advisors’s Bristol-Myers Squibb BMY Stock Holding History

GraniteShares Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,229	Closed	-$398K	–	102
2023 Q2	$398K	Sell	6,229 -159	-2%	-$10.7K	0.36%	70
2023 Q1	$443K	Sell	6,388 -101	-2%	-$7.12K	0.39%	77
2022 Q4	$467K	Sell	6,489 -1,387	-18%	-$105K	0.39%	96
2022 Q3	$559K	Sell	7,876 -558	-7%	-$40.5K	0.45%	77
2022 Q2	$649K	Sell	8,434 -1,428	-14%	-$109K	0.48%	75
2022 Q1	$720K	Sell	9,862 -1,007	-9%	-$67.6K	0.39%	89
2021 Q4	$677K	Buy	+10,869	New	+$638K	0.31%	103

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GraniteShares Advisors's BMY Position: Q3 2023 in Review

GraniteShares Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 6,229 shares — an estimated $398K sold.

GraniteShares Advisors first reported a position in BMY in Q4 2021 and held it in 7 quarters. The position peaked at $720K in Q1 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

GraniteShares Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
GraniteShares Advisors sold 6,229 Bristol-Myers Squibb shares in Q3 2023, an estimated $398K.
GraniteShares Advisors first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 7 quarters.
GraniteShares Advisors's Bristol-Myers Squibb position peaked at $720K in Q1 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on GraniteShares Advisors's 13F filing for Q3 2023, filed 31 Oct 2023.